New Avandia Study Finds Higher Risk Of Heart Problems And Death

A new Canadian study on older patients who took diabetes medications known as thiazolidinediones (which include rosiglitazone or Avandia), concluded they ran a significantly higher risk of congestive heart failure, heart attack, and death compared with patients on other diabetes drugs. The researchers said their study provides further evidence that thiazolidinediones (TZDs) do more harm than good. [click link for full article]

More: continued here

Filed under: Clinical Trials on December 15th, 2007